Cholinergic agonists stimulate calcium uptake and cGMP formation in human erythrocytes.
Human erythrocytes possess a muscarinic cholinergic receptor sensitive to cholinergic agonists which stimulate transient increases in calcium uptake and subsequent cyclic GMP formation. These phenomena can be blocked by atropine and EGTA. The cholinergic stimulation of cyclic GMP formation depends on Ca2+ uptake from external media. The effects of cholinergic agonists on the erythrocyte resemble their effect on calcium channels in nervous tissue. The cholinergic stimulation of Ca2+ uptake in erythrocytes may affect the calcium-sensitive mechanism involved in the shape, permeability and rigidity of these cells.
D001285:Atropine / Q000494:pharmacology*; D001693:Biological Transport, Active / Q000187:drug effects; D000001:Calcimycin / Q000494:pharmacology; D002118:Calcium / Q000097:blood*; D002217:Carbachol / Q000494:pharmacology*; D006152:Cyclic GMP / Q000097:blood*; D004533:Egtazic Acid / Q000494:pharmacology; D004910:Erythrocyte Membrane / Q000187:drug effects / Q000378:metabolism; D004912:Erythrocytes / Q000378:metabolism*; D006801:Humans; D007700:Kinetics; D011976:Receptors, Muscarinic / Q000378:metabolism*; D014268:Trifluoperazine / Q000494:pharmacology*
D011976:Receptors, Muscarinic; D014268:Trifluoperazine; D000001:Calcimycin; D004533:Egtazic Acid; D001285:Atropine; D002217:Carbachol; D006152:Cyclic GMP; D002118:Calcium